This suggests that APN may inhibit prostate cancer development by influencing the activity of signaling pathways or transcript factors involved in the tumorigenesis, proliferation, invasion, and/or metastatic activity of cancer cells. The gene discussed is ANPEP; the disease is prostate cancer.